Sepsis

Bronnen en Literatuur

Bronnen

• CBS Doodsoorzakenstatistiek. Gegevens omtrent de doodsoorzaken van alle in Nederlandse bevolkingsregisters ingeschreven overledenen.
• LMR. Landelijke Medische Registratie (Dutch Hospital Data).
• PREZIES. Preventie Ziekenhuisinfecties door Surveillance (CBO/RIVM)
• WHO Mortality database. WHO mortality database

Literatuur

• Annane D, Sebille V, Charpentier C.Effect of treatment with low doses of hydrocortison and fluorocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-71.
• Armstrong D.Infections in patients with neoplastic disease. In: Infections in the Immunocompromised Host; Pathogenesis, Prevention and Therapy. Amsterdam: Elsevier/North Holland, 1980: 129-158.
• Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez DA, et al.Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
• Bone RC, Grodzin CJ, Balk RA.Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997; 112: 235-43.
• Bone RC, Sprung CL, Sibbald WJ.Definitions for sepsis and organ failure. Crit Care Med 1992; 20: 724-6.
• Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, et al.Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. JAMA, 1995; 274: 968-74.
• Brun-Buisson C.The epidemiology of the systemic inflammatory response. Intensive-Care-Med 2000; 26(1): S64-74.
• Bryan CS, Reynolds KL, Brenner ER.Analysis of 1186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis 1983; 5: 629-638.
• Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y.Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. CID, 2003; 36: 53-9.
• Edgeworth JD, Treacher DF, Eykyn SJ.A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit-Care-Med, 1999; 27(8): 1421-8.
• Fisher CJ, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, et al.Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. N Engl J Med, 1996; 334: 1697-1702.
• Geubbels ELPE, Nagelkerke NJD, Mintjes-de Groot AJ, Vandenbroucke-Grauls CMJE, Grobbee DE, Boer AS de.Reduced risk of surgical site infection with longer hospital participation in a surveillance network. In: Prevention of surgical site infections through surveillance [thesis]. Utrecht: Utrecht University, 2003.
• Heyland DK, Hopman W, Coo H, Tranmer J, McColl MA.Long-term health-related quality of life in survivors of sepsis. Crit Care Med 2000; 28: 3599-605.
• Hotchkiss RS, Karl IE.The pathofysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-150.
• Keefer CS.The clinical significance of bacteremia. N Y State Med J 1941; 41: 976-981.
• Kieft H, Hoepelman AIM, Zhou W, Rozenberg-Arska M, Struyvenberg A, Verhoef J.The sepsis syndrome in a Dutch university hospital: Clinical observations. Arch Intern Med 1993; 153: 2241-47.
• Kreger BE, Craven DE, Carling PC, McCabe WR.Gram-negative bacteremia. III Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med 1980a; 68: 332-343.
• Kreger BE, Craven DE, McCabe WR.Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980b; 68: 344-355.
• Lark RL, Chenoweth C, Saint S, Zemencuk JK, Lipsky BA, Plorde JJ.Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. Diagn-Microbiol-Infect-Dis 2000; 38(3): 131-40
• Martin GS, Mannino DM, Eaton S, Moss M.The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-54.
• McBean M, Rajamani S.Increasing rates of hospitalization due to septicemia in the US elderly population, 1986 -1997. J Infect Dis, 2001; 183 (4): 596-603.
• Mintjes-Groot de AJ, Hassel CA van, Kaan JA, Verkooyen RP, Verbrugh HA.Impact of hospital-wide surveillance on hospital-acquired infections in an acute-care hospital in the Netherlands. J Hosp Infect, 2000; 46: 36-42.
• Parrillo JE, Parker MM, Natanson C, et al.Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann Intern Med 1990; 113: 227-242.
• Perl TM, Dvorak L, Hwang T, Wenzel RP.Long-term survival and function after suspected gram-negative sepsis. JAMA, 1995; 274; 338-45.
• Talsma E, Mintjes-de Groot AJ, Batenburg LA, Geubbels ELPE, Berg JMJ van den, Boer AS de. PREZIES: PREventie van ZIEkenhuisinfecties door Surveillance. Deelcomponent lijnsepsis, pilot 1999. RIVM-rapport nr. 212200009. Bilthoven/Utrecht: RIVM/CBO,1999.
• Verbrugh HA, Mintjes-de Groot AJ, Broers DA.Bacteriaemie in twee algemene ziekenhuizen: het topje van de ijsberg van ziekenhuisinfecties. Ned Tijdschr Geneeskd 1986; 130: 441-445.
• Wenzel RP.The mortality of hospital-acquired bloodstream infections: need for a new vital statistic? Int J Epidemiol 1988; 17: 225-7.
• Wheeler JG, Sethi D, Cowden JM, Wall PG, Rodrigues LC, Tompkins DS.Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. BMJ 1999; 318: 1046-50.